Document is current
Any future updates will be listed below
-
Authors
Chen, Ruqin
Johnson, Jeffrey
Rezazadeh, Ali https://orcid.org/0000-0002-3265-2391
Dudek, Arkadiusz Z https://orcid.org/0000-0002-9114-8945
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct06783270 at ClinicalTrials.govDocuments that mention this clinical trial
601 Assessment of CRISPR PD-1 edited tumor-infiltrating lymphocytes in infusion products for adoptive cell therapy in metastatic melanoma
https://doi.org/10.1136/jitc-2025-sitc2025.0601
Tumour-infiltrating lymphocyte therapy landscape: prospects and challenges
https://doi.org/10.1136/bmjonc-2024-000566
The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee
https://doi.org/10.1136/jitc-2025-013420
-
Funding
Funding for this research was provided by:
Mayo Clinic (Comprehensive Cancer Center Grant P30 CA015083)
- License Information
